Small Lesion Detectability #1

Patient History
Patient with history of Melanoma referred to PET/CT for restaging and metastatic evaluation.

Patient BMI
22.6

Acquisition
15 minutes
298 MBq / 8 mCi FDG
96 minute uptake

Conclusion
DISCOVERY MI sensitivity and LightBurst Digital Detector simultaneously provide excellent image quality and resolution. Discovery MI enables greater confidence when looking for small metastatic disease in difficult areas such as the liver.

Courtesy of Stanford University, A. Iagaru, MD

product-product-categories-pet-ct-discover mi image gallery-tab image new.jpg

product-product-categories-pet-ct-discover mi image gallery-tab image 4 new.jpg

Follow-up contrast enhanced CT confirms the presence of a small lesion detected by Discovery MI's digital PET detection technology.

Small Lesion Detectability #2

Patient History
Patient with history of Head and Neck cancer referred to PET/CT to evaluate extent of disease and lymph node involvement.

Patient BMI
25.6

Acquisition
2 minutes / FOV
329 MBq / 8.9 mCi FDG
65 minute uptake

Conclusion
Discovery MI sensitivity and LightBurst Digital Detector simultaneously provide excellent image quality and resolution. Discovery MI provides excellent small lesion detectability for assessing small lymph node involvement in the Head and Neck area.

Courtesy University of Zurich

product-product-categories-molecular-imaging-discovery mi -new-small lesion 1.png

Small Lesion Detectability #3

Patient History
Patient with history of Prostate cancer referred to PET/CT with new bone pain. Evaluation of metastatic disease.

Patient BMI
27.4

Acquisition
25 minutes
270 MBq / 7.3 mCi 18F - NAF
113 minute uptake

Conclusion
Discovery MI sensitivity and clinical resolution provide small lesion detectability for small bone lesions.

Courtesy Stanford University, A. Iagaru, MD
PET Radiopharmaceutical may not be approved by ministers of health in all regions.

product-product-categories-molecular-imaging-discovery mi -new-test.png

Small Lesion Detectability #4

Low noise imaging demonstrates excellent image quality / small lesion detectability.

Courtesy Stanford University, A. Iagaru, MD. PET Radiopharmaceutical may not be approved by ministers of health in all regions.

product-product-categories-molecular-imaging-discovery mi -new-small lesion 3b.png